144 related articles for article (PubMed ID: 38093588)
1. QSAR Studies of Nitric Oxide Synthase Inhibitors.
Tsopka IC; Hadjipavlou-Litina D
Curr Top Med Chem; 2023; 23(29):2723-2734. PubMed ID: 38093588
[TBL] [Abstract][Full Text] [Related]
2. Structural requirements for inhibition of the neuronal nitric oxide synthase (NOS-I): 3D-QSAR analysis of 4-oxo- and 4-amino-pteridine-based inhibitors.
Matter H; Kotsonis P; Klingler O; Strobel H; Fröhlich LG; Frey A; Pfleiderer W; Schmidt HH
J Med Chem; 2002 Jul; 45(14):2923-41. PubMed ID: 12086480
[TBL] [Abstract][Full Text] [Related]
3. Current trends in QSAR on NO donors and inhibitors of nitric oxide synthase (NOS)*.
Kontogiorgis CA; Hadjipavlou-Litina D
Med Res Rev; 2002 Jul; 22(4):385-418. PubMed ID: 12111751
[TBL] [Abstract][Full Text] [Related]
4. Comparative Pharmacophore Modeling and QSAR Studies for Structural Requirements of some Substituted 2-Aminopyridine Derivatives as Inhibitors of Nitric Oxide Synthases.
Sharma MC
Interdiscip Sci; 2015 Jun; 7(2):100-12. PubMed ID: 26202943
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of neuronal nitric oxide synthase by 4-amino pteridine derivatives: structure-activity relationship of antagonists of (6R)-5,6,7,8-tetrahydrobiopterin cofactor.
Fröhlich LG; Kotsonis P; Traub H; Taghavi-Moghadam S; Al-Masoudi N; Hofmann H; Strobel H; Matter H; Pfleiderer W; Schmidt HH
J Med Chem; 1999 Oct; 42(20):4108-21. PubMed ID: 10514281
[TBL] [Abstract][Full Text] [Related]
6. Spectroscopic and quantum/classical mechanics based computational studies to compare the ability of Andrographolide and its derivative to inhibit Nitric Oxide Synthase.
A S BG; Prasana JC; Muthu S; Abraham CS; David HA
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Jul; 218():374-387. PubMed ID: 31030004
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide synthase inhibitors: a review of patents from 2011 to the present.
Yang Y; Yu T; Lian YJ; Ma R; Yang S; Cho JY
Expert Opin Ther Pat; 2015 Jan; 25(1):49-68. PubMed ID: 25380586
[TBL] [Abstract][Full Text] [Related]
8. A QSAR and molecular modeling study on a series of 3, 4-dihydro-1-isoquinolinamines and thienopyridines acting as nitric oxide synthase inhibitors.
Kumar V; Gupta SP
Indian J Biochem Biophys; 2013 Feb; 50(1):72-9. PubMed ID: 23617077
[TBL] [Abstract][Full Text] [Related]
9. Pharmacophore and QSAR Modeling of Neuronal Nitric Oxide Synthase Ligands and Subsequent Validation and In Silico Search for New Scaffolds.
Suaifan G; Shehadeh M; Al-Ijel H; Al-Jamal KT; Taha M
Med Chem; 2016; 12(4):371-93. PubMed ID: 26427928
[TBL] [Abstract][Full Text] [Related]
10. Investigation on Quantitative Structure Activity Relationships of a Series of Inducible Nitric Oxide.
Sharma MC; Sharma S
Interdiscip Sci; 2016 Dec; 8(4):346-351. PubMed ID: 27272764
[TBL] [Abstract][Full Text] [Related]
11. Biology and chemistry of the inhibition of nitric oxide synthases by pteridine-derivatives as therapeutic agents.
Matter H; Kotsonis P
Med Res Rev; 2004 Sep; 24(5):662-84. PubMed ID: 15224385
[TBL] [Abstract][Full Text] [Related]
12. Cytokines in terms of QSAR. Review, evaluation and comparative studies.
Konstantinidou M; Hadjipavlou-Litina D
SAR QSAR Environ Res; 2013 Nov; 24(11):883-962. PubMed ID: 24099567
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic manipulation of nitric oxide signaling: targeting NOS dimerization and protein-protein interactions.
Paige JS; Jaffrey SR
Curr Top Med Chem; 2007; 7(1):97-114. PubMed ID: 17266598
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for isoform-selective inhibition in nitric oxide synthase.
Poulos TL; Li H
Acc Chem Res; 2013 Feb; 46(2):390-8. PubMed ID: 23030042
[TBL] [Abstract][Full Text] [Related]
15. Phenyl Ether- and Aniline-Containing 2-Aminoquinolines as Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase.
Cinelli MA; Li H; Pensa AV; Kang S; Roman LJ; Martásek P; Poulos TL; Silverman RB
J Med Chem; 2015 Nov; 58(21):8694-712. PubMed ID: 26469213
[TBL] [Abstract][Full Text] [Related]
16. Regulation of boar sperm functionality by the nitric oxide synthase/nitric oxide system.
Staicu FD; Lopez-Úbeda R; Romero-Aguirregomezcorta J; Martínez-Soto JC; Matás Parra C
J Assist Reprod Genet; 2019 Aug; 36(8):1721-1736. PubMed ID: 31325069
[TBL] [Abstract][Full Text] [Related]
17. Comparative pharmacophore modeling and QSAR studies for structural requirements of some substituted 2-aminopyridines derivatives as inhibitors nitric oxide synthases.
Sharma MC
Interdiscip Sci; 2014 Sep; ():. PubMed ID: 25183347
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide in skeletal muscle: inhibition of nitric oxide synthase inhibits walking speed in rats.
Wang MX; Murrell DF; Szabo C; Warren RF; Sarris M; Murrell GA
Nitric Oxide; 2001 Jun; 5(3):219-32. PubMed ID: 11384195
[TBL] [Abstract][Full Text] [Related]
19. Considering autotaxin inhibitors in terms of 2D-QSAR and 3D-mapping- review and evaluation.
Katsamakas S; Bermperoglou E; Hadjipavlou-Litina D
Curr Med Chem; 2015; 22(12):1428-61. PubMed ID: 25723504
[TBL] [Abstract][Full Text] [Related]
20. A quantitative structure-activity relationship (QSAR) study on a few series of potent, highly selective inhibitors of nitric oxide synthase.
Bharti VD; Gupta SP; Kumar H
Indian J Biochem Biophys; 2014 Feb; 51(1):29-36. PubMed ID: 24791414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
